21 CFR § 862.3610 Clinical Chemistry and Clinical Toxicology Devices

§ 862.3610 Methamphetamine test system.

Current through Sep 8, 2026 · Read all of Part 862

⚠ 2 pending changes to Part 862

(a) Identification. A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.

(b) Classification. Class II (special controls). A methamphetamine test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

[52 FR 16122, May 1, 1987, as amended at 84 FR 71798, Dec. 30, 2019; 91 FR 63486, Oct. 6, 2026]

← § 862.3600 Mercury test system.§ 862.3620 Methadone test system. →